World Bulletin / News Desk
Open access worldwide to the new database, based on genome studies, is expected to help researchers accelerate development of new drugs and better match patients with therapies, NCI said in a statement on Monday.
"Most anti-cancer drugs that are used today are used based on their empirical activity," Dr. Yves Pommier, chief of the NCI's Laboratory of Molecular Pharmacology, said in an interview. "For most of them, we know there is a target, but they have not been connected with any genomics."
Most cancer treatments involve a lot of guess work because doctors have no way to determine how a particular patient is likely to respond to many commonly used drugs or chemotherapy, or which cancers will develop resistance.
To create the database, the NCI team sequenced 60 human cancer cell lines, generating an extensive list of cancer-specific variations for different parts of the body.
"Only about half of women with ovarian cancer respond to it," he said, noting that pharmaceutical companies would have little incentive to determine if an existing cancer drug should only be used in a subset of patients.
Many recently approved cancer drugs are targeted treatments, designed to block specific pathways that cancer cells use to grow and reproduce. Before the drugs are administered, patients are tested for the specific genetic mutations that would make the drug more likely to be beneficial to them.
Melanoma drug Zelboraf, sold by Roche Holding AG, is designed to work by targeting a specific genetic mutation found in about half of all melanomas. Pfizer Inc's cancer drug Xalkori, which targets a mutation in the ALK gene, works in about 4 percent of lung cancer patients.
Would create new distribution, content creation giant, if approved by regulators
Waves of cyberattacks disrupt services for many East Coast US Internet users
Critics slam company after claims it allowed NSA to scan all users’ emails
Shenzhou-11 to take 2 astronauts into space, dock with orbiting space lab Tiangong-2 within 2 days
A German politician has said Facebook should pay for failing to remove online hate comment
For the first time in over 120 years, a design patent case will be heard by the US supreme court.
Toyota is usually associated with cars, but it has been investing millions in robotics and Kirobo is its first commercial foray into the sector.
A joint Mongolian-Japanese expedition found the giant print, which measures 106 centimetres (42 inches) long and 77 centimetres wide.
Current conditions may ‘commit Earth to an eventual total warming of 5 degrees Celsius’ in few thousand years, author says
Cyber-attack in 2014 likely the largest data breach in history
Photographs, videos, polls, quoted tweets no longer count toward 140-character limit
2.5 million phones recalled days before Apple introduces iPhone 7
Mark Zuckerberg has vowed to continue effort to provide satellite for Africa
3.7-billion-year-old rock suggests life began soon after Earth’s formation
Facebook will target advertising to Whatsapp users but will steer clear of third party advertising content
The global seed giant Monsanto is pulling its application to introduce GMO cotton seed after a row with the Indian government, which is demanding the company share its technology with local seed companies.